Citation Impact
Citing Papers
Carotenoids: biochemistry, pharmacology and treatment
2016 Standout
Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution
2018
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
2017 Standout
Dextromethorphan as a potential rapid-acting antidepressant
2011
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial
2019
Hesperidin exerts antidepressant-like effects in acute and chronic treatments in mice: Possible role of l-arginine-NO-cGMP pathway and BDNF levels
2014
Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus
2014
Gardenia jasminoides Ellis: Ethnopharmacology, phytochemistry, and pharmacological and industrial applications of an important traditional Chinese medicine
2020 Standout
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers
2019 Standout
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
2016 Standout
Psychedelics
2016 Standout
Clinical applications of hallucinogens: A review.
2016
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Prostate cancer risk and exposure to pesticides in British Columbia Farmers
2010
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences
2020 Standout
The neural basis of psychedelic action
2022 Standout
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
2013 Standout
Apigenin reverses depression-like behavior induced by chronic corticosterone treatment in mice
2016
Ayahuasca: Pharmacology, neuroscience and therapeutic potential
2016
Classical psychedelics for the treatment of depression and anxiety: A systematic review
2019
A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum
2017
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
2018
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
2016
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
The Therapeutic Potential of Apigenin
2019 Standout
A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
2021
Instant and Persistent Antidepressant Response of Gardenia Yellow Pigment Is Associated with Acute Protein Synthesis and Delayed Upregulation of BDNF Expression in the Hippocampus
2016
Maternal exposure to the mixture of organophosphorus pesticides induces reproductive dysfunction in the offspring
2011
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
2015
Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
2017
Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental Models
2014 Standout
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of Roberto B. Stringari being referenced
Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
2009
Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus
2010
Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?
2009
Harmine and Imipramine Promote Antioxidant Activities in Prefrontal Cortex and Hippocampus
2010
Effects of β-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: Further evidence of antidepressant properties
2009
Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain
2011
DNA Damage after Acute and Chronic Treatment with Malathion in Rats
2008
Administration of Harmine and Imipramine Alters Creatine Kinase and Mitochondrial Respiratory Chain Activities in the Rat Brain
2011